PPIL3 and cancer: To further investigate whether CYPJ can serve as a potential therapeutic target for macrophage-based cancer therapy, we replenished CYPJ in KO-BMDM using the rAAV method and then mixed them with Hepa1-6 cells for subcutaneous injection into wild-type mice (Figure 6A).